|
| Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Pneumonia
|
2017
|
NHLBI
|
5K23HL125982-02
|
|
An evaluation of sensor technology to monitor and report compliance with an evidence-based intervention to prevent ventilator-associated pneumonia
|
RAWAT, NISHI
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$198,331
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI110618-03
|
|
Pneumococcal pathogenesis in sickle cell disease
|
ROSCH, JASON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$445,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI116575-02
|
|
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved
|
SMITH, KENNETH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$309,000
|
|
Pneumonia
|
2017
|
NHLBI
|
2R01HL113022-06
|
|
Human Mesenchymal Stem Cell Microvesicles for the Treatment of Acute Lung Injury
|
LEE, JAE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$565,689
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI105147-03
|
|
Database designed novel anti-MRSA peptides
|
WANG, GUANGSHUN
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$376,250
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI121386-02
|
|
Targeting Innate Immunity in Staphylococcal Infection
|
GERARD, NORMA
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$442,500
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI104841-04
|
|
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae
|
WRIGHT, DENNIS
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$696,770
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI114800-03
|
|
Cardiac microlesion formation during invasive pneumococcal disease
|
ORIHUELA, CARLOS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$364,297
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI106893-03
|
|
Chlamydia virulence: exploitation of host N-glycosylation
|
CAMPBELL, LEE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$386,250
|
|
Pneumonia
|
2017
|
NIAAA
|
1K08AA024512-01A1
|
|
Alcohol inhibits anti-oxidant and immune defenses in the lung
|
STAITIEH, BASHAR
|
EMORY UNIVERSITY
|
GA
|
$191,430
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI118861-02
|
|
Innate immune-mediated control of pulmonary Legionella pneumophila infection
|
SHIN, SUNNY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$400,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI121804-02
|
|
Molecular mechanism of Mincle mediated NET formation:Implications for pneumonic sepsis
|
SHARMA, JYOTIKA
|
UNIVERSITY OF NORTH DAKOTA
|
ND
|
$347,500
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI117288-02
|
|
Passive and Active Immunization for Pneumocystis
|
GIGLIOTTI, FRANCIS
|
UNIVERSITY OF ROCHESTER
|
NY
|
$465,229
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI113720-03
|
|
Neutrophil Function in Bacterial Pneumonia
|
JEYASEELAN, SAMITHAMBY
|
LOUISIANA STATE UNIV A&M COL BATON ROUGE
|
LA
|
$369,629
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI116420-02
|
|
New antifungals targeting the synthesis of fungal sphingolipids
|
DEL POETA, MAURIZIO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$594,484
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL126094-03
|
|
Host-Pneumococcal Interaction in the Lung
|
DELA CRUZ, CHARLES
|
YALE UNIVERSITY
|
CT
|
$415,774
|
|
Pneumonia
|
2017
|
NHLBI
|
5K08HL126135-03
|
|
Cellular regulation of the IL-22 receptor and its importance in lung immunity.
|
WEATHINGTON, NATHANIEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$159,804
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI105168-05
|
|
Early Events in Pneumococcal Colonization
|
WEISER, JEFFREY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$423,750
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI116812-02
|
|
tRNA-derived RNA Fragments (tRFs) and their Functions in Respiratory Syncytial Virus (RSV) Infection
|
BAO, XIAOYONG
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
TX
|
$387,500
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI108479-04
|
|
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responses
|
JANOFF, EDWARD
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$441,714
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI121430-02
|
|
Rapid Identification of Optimal Combination Regimens for Pseudomonas aeruginosa
|
DRUSANO, GEORGE
|
UNIVERSITY OF FLORIDA
|
FL
|
$729,901
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI121604-02
|
|
Therapeutic Potential of Cystatin 9 Treatment to Fight Bacterial Pneumonia
|
EAVES-PYLES, TONYIA
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
TX
|
$176,127
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI100913-05
|
|
Bacterial inhibitors of eukaryotic membrane fusion
|
STARAI, VINCENT
|
UNIVERSITY OF GEORGIA
|
GA
|
$334,125
|
|
Pneumonia
|
2017
|
NHLBI
|
5K24HL111316-05
|
|
Forging a road to personalized medicine in interstitial lung diseases
|
FLAHERTY, KEVIN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$181,756
|
|
Pneumonia
|
2017
|
NHLBI
|
5R37HL079142-13
|
|
Th17 Cytokines and Lung Immunity
|
KOLLS, JAY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$255,986
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL117976-04
|
|
Epithelial mechanisms of inducible resistance to AML-associated pneumonia
|
EVANS, SCOTT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$400,000
|
|
Pneumonia
|
2017
|
NIGMS
|
5R01GM114561-02
|
|
Structural Investigations Of Macromolecular Complexes Critical To hRSV Life Cycle
|
WRIGHT, ELIZABETH
|
EMORY UNIVERSITY
|
GA
|
$387,033
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI121689-02
|
|
Development of therapeutic bacteriophages against carbapenemase-resistant Klebsiella pneumoniae
|
GILL, JASON
|
TEXAS A&M AGRILIFE RESEARCH
|
TX
|
$235,888
|
|
Pneumonia
|
2017
|
NIAID
|
5F30AI118376-03
|
|
Exogenous PGI2 protection against RSV-induced illness
|
BLOODWORTH, MELISSA
|
VANDERBILT UNIVERSITY
|
TN
|
$30,778
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI117338-02
|
|
Genomic variation in epidemic carbapenem-resistant K.pneumoniae
|
CHEN, LIANG
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
NJ
|
$198,750
|
|
Pneumonia
|
2017
|
NHLBI
|
5K08HL130595-03
|
|
DNA-Damage Repair In Pulmonary Fibrosis
|
KROPSKI, JONATHAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$157,248
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI117247-02
|
|
Predicting species-wide virulence for a bacterial pathogen with a large pan-genome
|
VAN OPIJNEN, TIM
|
BOSTON COLLEGE
|
MA
|
$234,750
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI101285-05
|
|
Coordinate regulation of competence and pneumocin production in S. pneumoniae
|
DAWID, SUZANNE
|
UNIVERSITY OF MICHIGAN
|
MI
|
$381,389
|
|
Pneumonia
|
2017
|
NHLBI
|
5P01HL114453-04
|
7097
|
Intra- and extra-cellular signaling by Cardiolipin in Lung injury
|
KAGAN, VALERIAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$382,093
|
|
Pneumonia
|
2017
|
NHLBI
|
5P01HL114453-04
|
7098
|
Dysregulation of Innate Immune response in Bacterial Pneumonia by Cardiolipin
|
RAY, PRABIR
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$408,148
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL062052-20
|
|
T-Cells and P. Carinii Pneumonia
|
KOLLS, JAY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$46,384
|
|
Pneumonia
|
2017
|
NIAID
|
5K23AI121325-02
|
|
Biomarkers and Risk Stratification in Pediatric Community-Acquired Pneumonia
|
FLORIN, TODD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$188,977
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI104711-05
|
|
Structure and Mechanism of Programmed Ribosomal Frameshifting in SARS coronavirus
|
D'SOUZA, VICTORIA
|
HARVARD UNIVERSITY
|
MA
|
$380,250
|
|
Pneumonia
|
2017
|
NIAID
|
5R03AI123875-03
|
|
B1a Cell Function in Sickle Cell Disease
|
HOLODICK, NICHOL
|
WESTERN MICHIGAN UNIV SCHOOL OF MEDICINE
|
MI
|
$75,500
|
|
Pneumonia
|
2017
|
NIDCD
|
5R01DC013554-04
|
|
Pneumococcal transition from nasopharyngeal biofilm carriage to otitis media
|
CAMPAGNARI, ANTHONY
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$338,658
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI116998-02
|
|
Development of HTP Assay for Inhibitors of Aerobactin Production
|
GULICK, ANDREW
|
HAUPTMAN-WOODWARD MEDICAL RESEARCH INST
|
NY
|
$459,125
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL116472-05
|
|
Regulation of Innate Immunity by F-Box Proteins
|
CHEN, BEIBEI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI117205-02
|
|
The Response of Mitochondria to Legionella Infection of Macrophages
|
HOLLENBECK, PETER
|
PURDUE UNIVERSITY
|
IN
|
$188,034
|
|
Pneumonia
|
2017
|
NIAID
|
2P01AI060699-11
|
6205
|
Administrative Core
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$88,781
|
|
Pneumonia
|
2017
|
NIAID
|
2P01AI060699-11
|
6206
|
Animal/Virology Core
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$296,888
|
|
Pneumonia
|
2017
|
NIAID
|
2P01AI060699-11
|
6207
|
Project 1
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$79,982
|
|
Pneumonia
|
2017
|
NIAID
|
2P01AI060699-11
|
6208
|
Adaptive MERS coronavirus-cell entry pathways and their relevance to virulence and antiviral strategies
|
GALLAGHER, THOMAS
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$279,415
|
|
Pneumonia
|
2017
|
NIAID
|
2P01AI060699-11
|
6209
|
Project 3
|
MCCRAY, PAUL
|
UNIVERSITY OF IOWA
|
IA
|
$340,075
|
|
Pneumonia
|
2017
|
NIAID
|
2P01AI060699-11
|
6210
|
Project 4
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$195,438
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI120033-02
|
|
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
|
KOLLS, JAY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$141,401
|
|
Pneumonia
|
2017
|
NEI
|
5R01EY014362-14
|
|
Toll Like Receptors in Bacterial Keratitis
|
PEARLMAN, ERIC
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$386,250
|
|
Pneumonia
|
2017
|
NIGMS
|
5R01GM114315-03
|
|
Mechanisms of Chemokine Killing and Resistance of Streptococcus pneumoniae
|
WINKLER, MALCOLM
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$286,744
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI118422-02
|
|
Perturbing the HIV Reservoir with Immune Stimulation
|
SMITH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$766,465
|
|
Pneumonia
|
2017
|
NIAID
|
5R44AI122360-02
|
|
Therapeutic antibody for RSV
|
KAUVAR, LAWRENCE
|
TRELLIS BIOSCIENCE, LLC
|
CA
|
$1,499,589
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI123243-02
|
|
Defining human noncanonical inflammasome responses to Legionella pneumophila
|
SHIN, SUNNY
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$402,500
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI127465-01
|
|
Effector-mediated Ubiquitin Manipulation in Legionella Pneumophila Pathogenesis
|
LUO, ZHAO-QING
|
PURDUE UNIVERSITY
|
IN
|
$405,709
|
|
Pneumonia
|
2017
|
NIAID
|
5U19AI109680-04
|
7496
|
Inhibitors of Coronavirus Fidelity and Cap Methylation as Broadly Applicable
|
DENISON, MARK
|
VANDERBILT UNIVERSITY
|
TN
|
$997,727
|
|
Pneumonia
|
2017
|
NIAID
|
5U19AI109680-04
|
7500
|
Screening Core
|
BOSTWICK, JAMES
|
SOUTHERN RESEARCH INSTITUTE
|
AL
|
$207,386
|
|
Pneumonia
|
2017
|
NIAID
|
5P01AI112524-03
|
8424
|
Core B: Animal Studies
|
NIEWIESK, STEFAN
|
OHIO STATE UNIVERSITY
|
OH
|
$343,186
|
|
Pneumonia
|
2017
|
NIAID
|
5P01AI112524-03
|
8426
|
Project 2: Dr. Peeples
|
PEEPLES, MARK
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$124,620
|
|
Pneumonia
|
2017
|
NIDA
|
5R01DA037102-04
|
|
Marijuana smoke promotes dysfunctional macrophage responses to HIV and pneumonia
|
ROTH, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$444,706
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI118955-02
|
|
Programmed cell death in P. aeruginosa
|
DOVE, SIMON
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$534,715
|
|
Pneumonia
|
2017
|
NIAID
|
1R03AI128228-01
|
|
Mechanism and structure of a novel activator of an alternative Sigma factor regulating competence
|
MORRISON, DONALD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$75,953
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI128338-01
|
|
Chromosomal and plasmid contributions to colistin resistance and virulence in KPC-producing Klebsiella pneumoniae
|
NGUYEN, M. HONG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$247,804
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL119190-05
|
|
Directed Culturing of Pneumocystis Using Metatranscriptomics
|
CUSHION, MELANIE
|
UNIVERSITY OF CINCINNATI
|
OH
|
$391,150
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI114736-03
|
|
Engineering protease-resistant alpha-beta peptides for broad-spectrum antivirals
|
MOSCONA, ANNE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$718,514
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL081784-10
|
|
Regulation of F box Proteins in Acute Lung Injury
|
MALLAMPALLI, RAMA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,000
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL118408-06
|
|
Oxidative Burst in Influenza and MRSA Co-infection
|
SUN, KEER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$376,250
|
|
Pneumonia
|
2017
|
NIA
|
5P01AG027296-09
|
5771
|
STUDY OF HOSPITALS STAFFING ATTENDING PHYSICIAN ROLE FOR PATIENTS AT END OF LIFE
|
TENO, JOAN
|
BROWN UNIVERSITY
|
RI
|
$257,866
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL123540-04
|
|
CXCR4 signaling in lung epithelial repair
|
WATERS, CHRISTOPHER
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$375,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI123558-02
|
|
Development of a diagnostic test for hypervirulent Klebsiella pneumoniae
|
RUSSO, THOMAS
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$199,375
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI121729-02
|
|
Efficacy of a novel nanoparticle vaccine and nutrition during RSV infection
|
MCGILL, JODI
|
KANSAS STATE UNIVERSITY
|
KS
|
$225,000
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL092020-08
|
|
Enhancing neutrophil function in neutropenia-related pneumonia
|
LUO, HONGBO
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$442,500
|
|
Pneumonia
|
2017
|
NHLBI
|
5K24HL087713-09
|
|
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases
|
HUANG, LAURENCE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$181,443
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL126711-03
|
|
Combined viral and bacterial infection and zinc homeostasis in distal lung
|
KAYNAR, A. MURAT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI117211-02
|
|
Transferrin Combination Therapy to Address Antimicrobial Resistance
|
SPELLBERG, BRAD
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$706,447
|
|
Pneumonia
|
2017
|
NIA
|
1R01AG052530-01A1
|
|
Impact of Heightened ER Stress on NLRP3 Activation in Aged Lung during Infection
|
STOUT-DELGADO, HEATHER
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$423,750
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI128756-01
|
|
Bioactivities of pneumococcal cell wall in neuropathogenesis
|
TUOMANEN, ELAINE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$448,750
|
|
Pneumonia
|
2017
|
NIAID
|
2R01AI090155-07A1
|
|
The molecular basis of the carbapenem resistance epidemic
|
KREISWIRTH, BARRY
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
NJ
|
$647,565
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI121076-02
|
|
Toward Rapid, Non-Invasive, Highly Sensitive, Multiplex Detection of Respiratory Pathogens
|
HILL, JANE
|
DARTMOUTH COLLEGE
|
NH
|
$196,372
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI122837-02
|
|
Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia
|
LEE, CHAO-HUNG
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$196,250
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI121731-02
|
|
Novel Pneumocystis Surface Proteins as Vaccines to Prevent Infection
|
RUAN, SANBAO
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$213,788
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL125435-03
|
|
Epigenetic Regulation in Acute Lung Injury
|
ZOU, CHUNBIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,000
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI123654-01A1
|
|
Antibody therapy for pneumococcal disease
|
PIROFSKI, LIISE-ANNE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
NY
|
$417,500
|
|
Pneumonia
|
2017
|
NIAID
|
5U19AI110819-04
|
6908
|
Genomics of Antibiotic Resistance in Bacterial Pathogens
|
FOUTS, DERRICK
|
J. CRAIG VENTER INSTITUTE, INC.
|
CA
|
$905,861
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI123815-02
|
|
CHARACTERIZATION OF LEGIONELLA TYPE IV SECRETION SIGNALS
|
VOGEL, JOSEPH
|
WASHINGTON UNIVERSITY
|
MO
|
$228,750
|
|
Pneumonia
|
2017
|
NIGMS
|
5K23GM110469-04
|
|
Salivary Cortisol as a Marker of Community-Acquired Pneumonia Severity in Adults
|
SELF, WESLEY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$170,639
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI123462-01A1
|
|
The non-canonical role of the CRISPR Cas2 nuclease in infection by Legionella pneumophila
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$227,370
|
|
Pneumonia
|
2017
|
NHLBI
|
1K08HL130557-01A1
|
|
Role of S-nitrosothiols in Akt1 signaling and pneumonia resolution
|
KRAFT, BRYAN
|
DUKE UNIVERSITY
|
NC
|
$118,157
|
|
Pneumonia
|
2017
|
NIAID
|
5R33AI111753-04
|
|
Circumventing Antibiotic Resistance with Novel Gene-Silencing Therapeutics
|
GREENBERG, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$443,512
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI123432-01A1
|
|
Trafficking Mechanism of Gram-Positive Bacterial Moonlighting Proteins
|
DYBVIG, KEVIN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$185,625
|
|
Pneumonia
|
2017
|
NHLBI
|
1R35HL135756-01
|
|
Pneumonia Biology
|
MIZGERD, JOSEPH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$868,938
|
|
Pneumonia
|
2017
|
NIAID
|
5U19AI109713-04
|
8682
|
Broad spectrum Tricyclics GyrB, ParE inhibitors for antibacterial applications
|
BARTIZAL, KENNETH
|
TRIUS THERAPEUTICS, INC.
|
CA
|
$533,920
|
|
Pneumonia
|
2017
|
NIAID
|
5U19AI109713-04
|
8688
|
Animal Model Core
|
PERLIN, DAVID
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
NJ
|
$698,460
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI122820-02
|
|
Reversing inhibitory receptor signaling for PcP Therapy
|
WRIGHT, TERRY
|
UNIVERSITY OF ROCHESTER
|
NY
|
$76,917
|
|
Pneumonia
|
2017
|
NHLBI
|
1R35HL135800-01
|
|
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
|
PRINCE, ALICE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$796,640
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI123682-01A1
|
|
ABC transporters necessary for intracellular survival of L. pneumophila
|
CAMBRONNE, ERIC
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$231,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI121947-02
|
|
Viral Modulation of Polysaccharide Antibody Responses and Vaccine Efficacy
|
HAAS, KAREN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$233,719
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI111965-04
|
|
New Tricks for 'Old' Drugs: PK/PD of Polymyxin Nonantibiotic Combinations
|
LI, JIAN
|
MONASH UNIVERSITY
|
AUSTRA
|
$855,749
|
|
Pneumonia
|
2017
|
NIGMS
|
1R01GM117519-01A1
|
|
Mechanisms of augmented host defenses after mild brain injury
|
REMICK, DANIEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$246,875
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL119682-04
|
|
Post Viral Bacterial Pneumonia: Role of MicroRNA and Autophagy
|
MOORE, BETHANY
|
UNIVERSITY OF MICHIGAN
|
MI
|
$387,500
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL123515-03
|
|
Novel IL-1 Family Members in Lung Innate Immunity
|
STANDIFORD, THEODORE
|
UNIVERSITY OF MICHIGAN
|
MI
|
$617,954
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL062150-25
|
|
Pneumocystis carinii: Macrophage & Epithelial Activation
|
LIMPER, ANDREW
|
MAYO CLINIC ROCHESTER
|
MN
|
$397,500
|
|
Pneumonia
|
2017
|
NIAID
|
1R43AI129218-01
|
|
Serotype independent therapeutic vaccine for Streptococcus pneumoniae
|
AMAN, M.
|
INTEGRATED BIOTHERAPEUTICS, INC.
|
MD
|
$247,510
|
|
Pneumonia
|
2017
|
NIAID
|
1R44AI129149-01
|
|
Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomics’ reduced genome E. coli strains
|
BLATTNER, FREDERICK
|
SCARAB GENOMICS, LLC
|
WI
|
$116,082
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL128156-03
|
|
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study
|
HUANG, LAURENCE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$728,630
|
|
Pneumonia
|
2017
|
NIAID
|
2R13AI063796-10
|
|
Biennial Meeting of the Chlamydia Basic Research Society
|
HEGEMANN, JOHANNES
|
CHLAMYDIA BASIC RESEARCH SOCIETY
|
AR
|
$6,000
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL132115-02
|
|
Regulation of distal lung epithelial regeneration by microRNA-Hippo pathway
|
TIAN, YING
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$393,500
|
|
Pneumonia
|
2017
|
NIAID
|
5K08AI112506-04
|
|
The Epidemiology of Multi-Drug Resistant Enterobacteriaceae Infections in Childre
|
LOGAN, LATANIA
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$190,679
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL091958-10
|
|
Neutrophil Accumulation in Bacterial Pneumonia
|
JEYASEELAN, SAMITHAMBY
|
LOUISIANA STATE UNIV A&M COL BATON ROUGE
|
LA
|
$369,456
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI114657-03
|
|
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1
|
MAKINO, SHINJI
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
TX
|
$456,581
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI120244-03
|
|
Molecular and Cellular Pathogenesis of Legionella
|
ABU KWAIK, YOUSEF
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$375,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI118805-03
|
|
Vaccine potential of the proline-rich domain of pneumococcal surface protein A
|
BRILES, DAVID
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$367,500
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI118876-03
|
|
Regulation of Memory B Cell Responses to Polysaccharide Antigens
|
HAAS, KAREN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$384,390
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI110098-04
|
|
Human Airway Colonization by Mycoplasma pneumoniae
|
KRAUSE, DUNCAN
|
UNIVERSITY OF GEORGIA
|
GA
|
$389,125
|
|
Pneumonia
|
2017
|
NIGMS
|
5R01GM115353-03
|
|
Serial, non-invasive molecular analysis of exhaled breath condensate to define the pulmonary flora in critically injured, ventilated adults
|
MAY, ADDISON
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$312,050
|
|
Pneumonia
|
2017
|
FIC
|
5D43TW007585-10
|
|
Infectious Diseases and Child Health in Pakistan Research Training Program.
|
ZAIDI, ANITA
|
AGA KHAN UNIVERSITY
|
PAKIST
|
$243,000
|
|
Pneumonia
|
2017
|
NIAID
|
5F32AI122516-03
|
|
Defining the molecular link between zinc deficiency and pneumonia
|
PALMER, LAUREN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$57,066
|
|
Pneumonia
|
2017
|
NIAAA
|
5R21AA024860-02
|
|
Chronic Alcohol Alteration of Influenza-Specific CD8 T cell Immunity and Protection
|
LEGGE, KEVIN
|
UNIVERSITY OF IOWA
|
IA
|
$179,969
|
|
Pneumonia
|
2017
|
NIA
|
5R01AG045044-05
|
|
Effects of aging and HIV infection on the response to pneumococcal vaccine
|
PIROFSKI, LIISE-ANNE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
NY
|
$505,454
|
|
Pneumonia
|
2017
|
NIA
|
5R01AG050607-03
|
|
Acquired deficiency of innate immunity (ficolin-2) among elderly adults
|
NAHM, MOON
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$316,050
|
|
Pneumonia
|
2017
|
NIA
|
5K99AG051784-02
|
|
The role of extracellular adenosine in age-driven susceptibility to S. pneumoniae lung infection
|
BOU GHANEM, ELSA
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$117,628
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI105215-04
|
|
The role of natural killer T cells in the innate response to lung infection
|
KRONENBERG, MITCHELL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$442,500
|
|
Pneumonia
|
2017
|
NIGMS
|
5P20GM113123-02
|
5923
|
Project 1
|
SHARMA, JYOTIKA
|
UNIVERSITY OF NORTH DAKOTA
|
ND
|
$251,159
|
|
Pneumonia
|
2017
|
NIGMS
|
5P20GM113132-02
|
6073
|
Project 4: Molecular Mechanisms of RSV F Activation and Inhibition
|
MCLELLAN, JASON
|
DARTMOUTH COLLEGE
|
NH
|
$275,702
|
|
Pneumonia
|
2017
|
NIDCD
|
5R01DC013833-03
|
|
Pathogenesis of pneumococcal otitis media
|
LI, JIAN-DONG
|
GEORGIA STATE UNIVERSITY
|
GA
|
$321,938
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL122307-03
|
|
Lung Epithelial-Immune Interactions In Respiratory Virus Infection
|
RAY, PRABIR
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$451,700
|
|
Pneumonia
|
2017
|
NIAID
|
5U19AI107810-05
|
8683
|
Role of Uncharacterized Genes in High Pathogenic Human Coronavirus Infection
|
BARIC, RALPH
|
UNIVERSITY OF NORTH CAROLINA SYSTEM
|
NC
|
$455,993
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI106786-05
|
|
Ecological and genetic contributions to the spread of resistance in pneumococcus
|
HANAGE, WILLIAM
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$650,362
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI125152-02
|
|
Plasma Gelsolin as Immunotherapeutic for Antibiotic-Resistant Pneumonia
|
KOBZIK, LESTER
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$970,844
|
|
Pneumonia
|
2017
|
NIDDK
|
5R01DK097112-03
|
|
Gastrointestinal Microflora Changes in Children Treated with Proton Pump Inhibitors
|
ROSEN, RACHEL
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$385,171
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL132862-02
|
|
HECT-domain E3 Ligase and Acute Lung Injury
|
CHEN, BEIBEI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$468,319
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL127805-02
|
|
HSCT-induced alterations in DCs to promote IL-17 and lung pathology
|
MOORE, BETHANY
|
UNIVERSITY OF MICHIGAN
|
MI
|
$485,074
|
|
Pneumonia
|
2017
|
NHLBI
|
5P01HL092870-07
|
8353
|
Genotype-Phenotype Interactions in Familial Interstitial Pneumonia
|
BLACKWELL, TIMOTHY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$459,172
|
|
Pneumonia
|
2017
|
NHLBI
|
5P01HL092870-07
|
8354
|
Genetic Basis of Pulmonary Fibrosis
|
PHILLIPS III, JOHN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$429,424
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI121891-02
|
|
Calcium dynamics and Legionella infection
|
SHUMAN, HOWARD
|
UNIVERSITY OF CHICAGO
|
IL
|
$197,500
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL114858-06
|
|
Autophagy regulation of RSV-induced pulmonary disease
|
LUKACS, NICHOLAS
|
UNIVERSITY OF MICHIGAN
|
MI
|
$420,332
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL133043-02
|
|
Smart stethoscope for monitoring and diagnosis of lung diseases
|
ELHILALI, MOUNYA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$555,270
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI126844-02
|
|
HSPGs in Alpha-toxin-induced Tissue Injury
|
PARK, PYONG WOO
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$221,250
|
|
Pneumonia
|
2017
|
NIAID
|
5K01AI103028-05
|
|
Carbapenem-Resistant Klebsiella Pneumoniae in Long-Term Acute Care Hospitals
|
HAN, JENNIFER
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$133,758
|
|
Pneumonia
|
2017
|
NIGMS
|
5R35GM118157-02
|
|
Interplay of Transition Metal Homeostasis and Reactive Sulfur Species in Bacterial Pathogens
|
GIEDROC, DAVID
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$583,775
|
|
Pneumonia
|
2017
|
NIAID
|
4R37AI041699-22
|
|
Genetic Analysis of Legionella Phagosome Trafficking
|
ROY, CRAIG
|
YALE UNIVERSITY
|
CT
|
$544,169
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI125445-02
|
|
Fine-tuning the Neutrophilic Response to Pneumonia
|
LOONEY, MARK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$450,348
|
|
Pneumonia
|
2017
|
NIGMS
|
5P20GM109035-02
|
6005
|
Project 3: Tolerance of Viral/Bacterial Co-infections
|
JAMIESON, AMANDA
|
BROWN UNIVERSITY
|
RI
|
$282,902
|
|
Pneumonia
|
2017
|
NIA
|
5R01AG045973-06
|
|
Immune response to pneumococcal vaccination in aging HIV positive adults.
|
WESTERINK, M.A.
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$298,409
|
|
Pneumonia
|
2017
|
NIAID
|
5K23AI121485-02
|
|
Longitudinal analysis of respiratory tract microbiome change and sequence-based infection diagnosis during mechanical ventilation
|
KELLY, BRENDAN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$195,696
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI109317-04
|
|
Lung innate immunity against bacterial infection
|
WU, MIN
|
UNIVERSITY OF NORTH DAKOTA
|
ND
|
$345,000
|
|
Pneumonia
|
2017
|
NIGMS
|
5P20GM109007-02
|
5949
|
Project 4: Role of Antecedent Influenza Infection in Severity and Outcome of Hemorrhagic MRSA Pneumonia
|
PARIMON, TANYALAK
|
IDAHO VETERANS RESEARCH / EDUCATION FDN
|
ID
|
$270,232
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI056289-15
|
|
Recombinant Attenuated Salmonella Vaccines for Humans
|
CURTISS III, ROY
|
UNIVERSITY OF FLORIDA
|
FL
|
$444,683
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI121820-02
|
|
The Role of Flagellar Motility to Innate Immune Recognition of Bacteria
|
BERWIN, BRENT
|
DARTMOUTH COLLEGE
|
NH
|
$208,170
|
|
Pneumonia
|
2017
|
NHLBI
|
5K08HL112849-05
|
|
Modulation of host immune defense by Pneumocystis beta-glucans
|
CARMONA PORQUERA, EVA
|
MAYO CLINIC ROCHESTER
|
MN
|
$165,456
|
|
Pneumonia
|
2017
|
NHLBI
|
1R01HL136706-01
|
|
Mechanisms of differential susceptibility of human SP-B genetic variants to pneumonia and lung injury
|
WANG, GUIRONG
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$405,000
|
|
Pneumonia
|
2017
|
NIAID
|
5P01AI063302-14
|
5518
|
Project 3: Post-transcriptional regulation of innate immunity to Legionella pneumophila
|
VANCE, RUSSELL
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$389,968
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI110724-03
|
|
The bacterial response to antibiotics and the evolution of antibiotic resistance
|
VAN OPIJNEN, TIM
|
BOSTON COLLEGE
|
MA
|
$391,250
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL124103-04
|
|
The Microbiome, Virome and Host Responses Preceding Ventilator-Associated Pneumon
|
MOURANI, PETER
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$635,764
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI089728-07
|
|
Receptor recognition and cell entry of coronaviruses
|
LI, FANG
|
UNIVERSITY OF MINNESOTA
|
MN
|
$453,437
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI038446-23
|
|
Mechanisms of pneumococcal persistence during carriage
|
WEISER, JEFFREY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$423,750
|
|
Pneumonia
|
2017
|
NIAID
|
7R01AI106721-04
|
|
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati
|
MELANDER, CHRISTIAN
|
NORTH CAROLINA STATE UNIVERSITY RALEIGH
|
NC
|
$507,293
|
|
Pneumonia
|
2017
|
NIAID
|
5U19AI090023-08
|
6552
|
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination
|
MULLIGAN, MARK
|
EMORY UNIVERSITY
|
GA
|
$472,599
|
|
Pneumonia
|
2017
|
NIAID
|
5U19AI090023-08
|
6556
|
System Biological Analyses of Adaptive Responses to vaccination
|
AHMED, RAFI
|
EMORY UNIVERSITY
|
GA
|
$863,178
|
|
Pneumonia
|
2017
|
NIAID
|
5U19AI090023-08
|
6557
|
Project 1 - System Biological Analyses of Innate Responses to Vaccination
|
PULENDRAN, BALI
|
EMORY UNIVERSITY
|
GA
|
$674,422
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI125999-02
|
|
Impact of Human STING Variants on Pneumococcal Vaccine Effectiveness
|
JIN, LEI
|
UNIVERSITY OF FLORIDA
|
FL
|
$187,500
|
|
Pneumonia
|
2017
|
NIAID
|
5K24AI104831-05
|
|
Patient-Oriented Research on Hospital-Acquired Pathogens
|
HAUSER, ALAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$100,048
|
|
Pneumonia
|
2017
|
NHLBI
|
5P01HL095489-07
|
7428
|
Cell signaling in granulocyte transfusion
|
LUO, HONGBO
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$445,696
|
|
Pneumonia
|
2017
|
NIAID
|
1R03AI130526-01
|
|
A murine model of Pseudomonas aeruginosa pneumonia secondary to hemorrhagic shock
|
LEFORT, CRAIG
|
RHODE ISLAND HOSPITAL
|
RI
|
$80,500
|
|
Pneumonia
|
2017
|
NIAID
|
5F30AI114262-04
|
|
The Role of Group 2 Innate Lymphoid Cells in RSV-Induced Airway Dysfunction
|
STIER, MATTHEW
|
VANDERBILT UNIVERSITY
|
TN
|
$42,597
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI115053-03
|
|
Lung-resident antibacterial heterotypic immunity
|
MIZGERD, JOSEPH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$409,250
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI118974-02
|
|
Subversion of membrane transport pathways by Legionella pneumophila
|
MUKHERJEE, SHAERI
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$396,250
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL130669-03
|
|
Aging and Innate Immune Mechanisms in Pulmonary Infection
|
BUCALA, RICHARD
|
YALE UNIVERSITY
|
CT
|
$416,250
|
|
Pneumonia
|
2017
|
NIGMS
|
5P20GM103646-05
|
8320
|
Identifying polyamine dependent mechanisms in pneumococcal pneumonia
|
NANDURI, BINDU
|
MISSISSIPPI STATE UNIVERSITY
|
MS
|
$289,155
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI125402-02
|
|
Defining redundant strategies central to Legionella replication vacuole formation
|
O'CONNOR, TAMARA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$405,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI126176-02
|
|
Pathogenesis of bacterial meningitis
|
KIM, KWANG
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$162,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI126109-02
|
|
Innate Immune Activation by Respiratory Syncytial Virus
|
KAHN, JEFFREY
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$202,500
|
|
Pneumonia
|
2017
|
NHLBI
|
3R01HL126094-03S1
|
|
Host-Pneumococcal Interaction in the Lung
|
DELA CRUZ, CHARLES
|
YALE UNIVERSITY
|
CT
|
$12,078
|
|
Pneumonia
|
2017
|
NIAID
|
5R43AI126999-02
|
|
Optimization of a mucosal RSV vaccine
|
YANG, KEJIAN
|
BIOMEDICAL RESEARCH MODELS, INC.
|
MA
|
$227,844
|
|
Pneumonia
|
2017
|
NEI
|
5R00EY025290-03
|
|
Structure-function Analysis of Bestrophins
|
YANG, TINGTING
|
UNIVERSITY OF ROCHESTER
|
NY
|
$249,000
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI125215-01A1
|
|
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury
|
VOGEL, STEFANIE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$547,143
|
|
Pneumonia
|
2017
|
NIAID
|
5R21AI126157-02
|
|
Microbiome and host response signatures for pneumonia among lung transplant recipients
|
CLANCY, CORNELIUS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$251,276
|
|
Pneumonia
|
2017
|
NIGMS
|
5R01GM091875-17
|
|
POPULATION DYNAMICS AND EVOLUTION OF ANTIBIOTIC TREATMENT AND RESISTANCE
|
LEVIN, BRUCE
|
EMORY UNIVERSITY
|
GA
|
$315,900
|
|
Pneumonia
|
2017
|
NHLBI
|
2R01HL107380-06A1
|
|
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia
|
ALCORN, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$387,813
|
|
Pneumonia
|
2017
|
NIGMS
|
1R01GM120060-01A1
|
|
Liver-derived protection during pneumonia and sepsis
|
QUINTON, LEE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$316,663
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI125307-01A1
|
|
Integrated modeling of Klebsiella pneumoniae infections based on bacterial genotype, patient factors and colonization status
|
BACHMAN, MICHAEL
|
UNIVERSITY OF MICHIGAN
|
MI
|
$560,442
|
|
Pneumonia
|
2017
|
NIAID
|
2R01AI093727-06A1
|
|
Role of the Plasminogen Activator Protease during Pneumonic Plague
|
LATHEM, WYNDHAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$462,195
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI125642-01A1
|
|
Risk Stratification and Decision Support to Improve Care and Outcomes in Children with Pneumonia
|
WILLIAMS, DEREK
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$781,455
|
|
Pneumonia
|
2017
|
NIAID
|
5F31AI122615-02
|
|
Reversing age-related defects in innate and adaptive immune responses to Streptococcus pneumoniae by oral supplementation with vitamin E
|
ROGGENSACK, SARA
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$39,784
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI125876-01A1
|
|
An essential RNA chaperone in Pseudomonas aeruginosa
|
DOVE, SIMON
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$265,500
|
|
Pneumonia
|
2017
|
NIAID
|
1K01AI125413-01A1
|
|
Metabolomics Evaluation of the Etiology of Pneumonia
|
AMBROGGIO, LILLIAM
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$128,250
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL130084-02
|
|
The role of acute kidney in the pathogenesis of sepsis from pneumonia
|
FAUBEL, SARAH
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$388,750
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI125968-01A1
|
|
Defining the Siderophore of Stenotrophomonas maltophilia, an Emerging, Multi-Drug Resistant Pathogen
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$228,356
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI053674-13
|
|
Mechanistic Studies of Patatin-like Toxins
|
HAUSER, ALAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$359,981
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI123048-03
|
|
Antibody Responses in Aging SIV Infected Monkeys
|
PAHWA, SAVITA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$817,006
|
|
Pneumonia
|
2017
|
NIA
|
5P01AG049665-03
|
6277
|
Mapping proteostasis in the lung
|
PERLMAN, HARRIS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$269,496
|
|
Pneumonia
|
2017
|
NICHD
|
1R03HD088909-01A1
|
|
Antibody & Cellular Immune responses in children after 2 vs 3 doses and pre vs post booster of PCV13 Vaccine
|
KAUR, RAVINDER
|
ROCHESTER GENERAL HOSPITAL (NY)
|
NY
|
$84,828
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI125780-01A1
|
|
Immune regulation by pneumococcus
|
ALEXANDER-MILLER, MARTHA
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$232,500
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI128520-01A1
|
|
A self-limited live RSV vaccine inducing anti- pre-fusion F antibodies
|
OOMENS, ANTONIUS
|
OKLAHOMA STATE UNIVERSITY STILLWATER
|
OK
|
$174,922
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI119558-01A1
|
|
Evaluating the Role of Neutrophils in the Progression of Pneumonic Plague
|
GOLDMAN, WILLIAM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$226,217
|
|
Pneumonia
|
2017
|
NIAID
|
5F30AI114146-04
|
|
Antigen discovery and validation in Pneumocystis pneumonia
|
EDDENS, TAYLOR
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$49,044
|
|
Pneumonia
|
2017
|
NIAID
|
5R44AI098197-04
|
|
Preclinical development of a potent D-peptide RSV inhibitor
|
WELCH, BRETT
|
NAVIGEN, INC.
|
UT
|
$999,998
|
|
Pneumonia
|
2017
|
NHLBI
|
5K08HL133445-02
|
|
Role of IL-33 in Influenza and Staphylococcus aureus Co-infection
|
ROBINSON, KEVEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$160,704
|
|
Pneumonia
|
2017
|
NIGMS
|
5R01GM111042-03
|
|
High-Throughput Assays for Inhibitors of Understudied Bacterial Proteases
|
KRITZER, JOSHUA
|
TUFTS UNIVERSITY MEDFORD
|
MA
|
$292,643
|
|
Pneumonia
|
2017
|
NIAID
|
5R41AI127009-02
|
|
Inhibitors of the viral nucleoprotein-polymerase co-factor interaction for human RSV and MPV therapy
|
MOIR, DONALD
|
MICROBIOTIX, INC
|
MA
|
$284,808
|
|
Pneumonia
|
2017
|
NIGMS
|
5P20GM103648-05
|
8210
|
Development of an RSV Vaccine by Molecular Manipulation of the Viral Matrix Prot
|
OOMENS, TOM
|
OKLAHOMA STATE UNIVERSITY STILLWATER
|
OK
|
$246,939
|
|
Pneumonia
|
2017
|
NIGMS
|
5P20GM103648-05
|
8213
|
Neutrophil-Mediated Acute Lung Injury in Influenza Virus Pneumonia
|
NARASARAJU, TELUGU
|
OKLAHOMA STATE UNIVERSITY STILLWATER
|
OK
|
$247,443
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI043987-19
|
|
Type II Secretion and Legionella pneumophila Infection
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$297,128
|
|
Pneumonia
|
2017
|
FIC
|
5K01TW009988-04
|
|
Pulse oximetry for childhood pneumonia in rural Bangladesh
|
MCCOLLUM, ERIC
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$140,385
|
|
Pneumonia
|
2017
|
NHLBI
|
1F31HL134205-01A1
|
|
Mechanisms of Liver Injury and Hepatoprotection During Pneumonia
|
KIM, YURI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$32,263
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI123208-02
|
|
Forecasting pneumococcal serotype frequencies to develop adult-specific vaccines
|
WEINBERGER, DANIEL
|
YALE UNIVERSITY
|
CT
|
$634,255
|
|
Pneumonia
|
2017
|
NHLBI
|
1F31HL137287-01
|
|
Role of Innate Immunity in Pneumonic Sepsis
|
PAUDEL, SAGAR
|
LOUISIANA STATE UNIV A&M COL BATON ROUGE
|
LA
|
$36,647
|
|
Pneumonia
|
2017
|
NIAID
|
5R01AI112402-05
|
|
Metabolic approaches to treat severe viral and inflammatory diseases
|
OCHOA, AUGUSTO
|
LSU HEALTH SCIENCES CENTER
|
LA
|
$517,128
|
|
Pneumonia
|
2017
|
NHLBI
|
1R13HL137316-01
|
|
Clinical & Translational Research in Pneumonia: Defining a Research Agenda for Today and Tomorrow
|
RAMIREZ, JULIO
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$5,000
|
|
Pneumonia
|
2017
|
NHLBI
|
1R01HL132573-01A1
|
|
Proteoglycan-Chemokine Interactions in Lung Disease
|
PARK, PYONG WOO
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$485,256
|
|
Pneumonia
|
2017
|
NIAID
|
5R42AI109926-03
|
|
Development of VLP vaccine for RSV
|
BLANCO, JORGE
|
SIGMOVIR BIOSYSTEMS, INC.
|
MD
|
$933,962
|
|
Pneumonia
|
2017
|
NHLBI
|
5K08HL133380-02
|
|
Transient Receptor Potential Vanilloid 4 (TRPV4) mediates the host defense and lung injury response to bacterial pneumonia
|
SCHERAGA, RACHEL
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$161,881
|
|
Pneumonia
|
2017
|
NINR
|
5R44NR015193-03
|
|
Development of novel, biophysically designed fluids for swallowing disorders
|
ROBBINS, JOANNE
|
SWALLOW SOLUTIONS, LLC
|
WI
|
$750,000
|
|
Pneumonia
|
2017
|
NIAID
|
5R41AI122433-02
|
|
T3SS needle protein inhibitors for the treatment of P. aeruginosa infection
|
MECSAS, JOAN
|
MICROBIOTIX, INC
|
MA
|
$297,758
|
|
Pneumonia
|
2017
|
NHLBI
|
5K08HL130582-02
|
|
The Role of Oncostatin-M in Pneumonia
|
TRABER, KATRINA
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$164,160
|
|
Pneumonia
|
2017
|
NIGMS
|
5U54GM088558-09
|
5072
|
Understanding and controlling antibiotic resistance
|
COHEN, THEODORE
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$42,050
|
|
Pneumonia
|
2017
|
NHLBI
|
5R01HL131829-02
|
|
Molecular Imaging for Pulmonary Infections and Inflammation
|
JAIN, SANJAY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$720,392
|
|
Pneumonia
|
2017
|
NHLBI
|
5R21HL128141-02
|
|
Tracheobronchial mucociliary dysfunction in HIV patients
|
UNWALLA, HOSHANG
|
FLORIDA INTERNATIONAL UNIVERSITY
|
FL
|
$182,836
|
|
Pneumonia
|
2017
|
NHLBI
|
5K23HL132120-02
|
|
Low risk in vivo diagnosis of IPF with optical imaging
|
HARIRI, LIDA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$179,120
|
|
Pneumonia
|
2017
|
NCATS
|
5R21TR001737-02
|
|
Quantum model repurposing of cethromycin for liver stage malaria
|
SULLIVAN, DAVID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$286,198
|
|
Pneumonia
|
2017
|
NEI
|
5R01EY016144-13
|
|
Pathogenesis of microbial anterior eye diseases
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$425,276
|
|
Pneumonia
|
2017
|
NIAID
|
1R41AI131742-01
|
|
Towards a New Generation of Glycoengineered Pneumococcal Bioconjugate Vaccines
|
FELDMAN, MARIO
|
VAXNEWMO, INC
|
MO
|
$210,129
|
|
Pneumonia
|
2017
|
NIA
|
5R01AG052608-02
|
|
Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines
|
BANCHEREAU, JACQUES
|
JACKSON LABORATORY
|
ME
|
$546,881
|
|
Pneumonia
|
2017
|
NHLBI
|
2R44HL127886-02A1
|
|
ARF6 Inhibitors for Treatment of Acute Lung Injury
|
MUELLER, ALAN
|
NAVIGEN, INC.
|
UT
|
$889,461
|
|
Pneumonia
|
2017
|
NIA
|
5R21AG055144-02
|
|
Inhibition of necroptosis during inflamm-aging and pneumonia
|
ORIHUELA, CARLOS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$220,500
|
|
Pneumonia
|
2017
|
NIA
|
5R01AG053553-02
|
|
Mucociliary clearance in aging
|
BAILEY, KRISTINA
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$308,525
|
|
Pneumonia
|
2017
|
NIEHS
|
5U01ES027292-02
|
|
Key Events in Modulation of Lung Infection Susceptibility by Nanomaterials
|
THRALL, BRIAN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
WA
|
$390,000
|
|
Pneumonia
|
2017
|
NICHD
|
1R01HD092239-01
|
|
Instrumental screening for dysphagia by combining high-resolution cervical auscultation with advanced data analysis tools to identify silent dysphagia and silent aspiration
|
SEJDIC, ERVIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$302,394
|
|
Pneumonia
|
2017
|
NIAID
|
2P01AI061093-13A1
|
5750
|
Human Genetic Dissection of Antibody Response to Pneumococcal Glycans
|
CASANOVA, JEAN-LAURENT
|
ROCKEFELLER UNIVERSITY
|
NY
|
$479,943
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI132154-01
|
|
Targeting the Urgent Need for New Antibiotics against Gram-negative ‘Superbugs’
|
LI, JIAN
|
MONASH UNIVERSITY
|
AUSTRA
|
$1,059,804
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI132413-01
|
|
Infection-homing nanosystems as antibacterial therapeutics-delivery platforms
|
SAILOR, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$836,708
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI132304-01
|
|
Broad spectrum antibacterials selectively targeting an un-drugged site on the ribosome
|
TESTA, CHARLES
|
CURZA GLOBAL, LLC
|
UT
|
$866,989
|
|
Pneumonia
|
2017
|
NHLBI
|
1R01HL137816-01
|
|
Strategies to Enhance Pneumonia Care via Intermediate Intensive Care (STEP IN)
|
COOKE, COLIN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$700,275
|
|
Pneumonia
|
2017
|
NIGMS
|
1R01GM124235-01
|
|
Fra-1-A20 Signaling and Resolution of Pneumonia-Induced Sepsis
|
REDDY, SEKHAR
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$307,808
|
|
Pneumonia
|
2017
|
NCI
|
1R01CA218148-01
|
|
imaging Radiation-Associated Dysphagia (iRAD)
|
FULLER, CLIFTON
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$261,800
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI133304-01
|
|
Confined Genetic Transformation and Exchange of Antibiotic Resistance Genes in Femtoliter Microdroplets
|
EDDINGTON, DAVID
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$223,779
|
|
Pneumonia
|
2017
|
NHLBI
|
1K08HL138289-01
|
|
Host-pathogen interactions that promote carbapenem-resistant Klebsiella pneumoniae pulmonary infection
|
AHN, DANIELLE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$166,212
|
|
Pneumonia
|
2017
|
NHLBI
|
1K01HL135476-01A1
|
|
Role of IL-22/IL-22RA2 during pneumococcal pneumonia
|
TREVEJO-NUNEZ, GIRALDINA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$167,292
|
|
Pneumonia
|
2017
|
NHLBI
|
1R01HL134870-01A1
|
|
Role of type III interferons in Staphylococcus aureus respiratory tract infection
|
PARKER, DANE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$400,000
|
|
Pneumonia
|
2017
|
NHLBI
|
3R43HL134456-01S1
|
|
Antimicrobial Endotracheal Tube to Combat Biofilm
|
NEFF, JENNIFER
|
ALLVIVO VASCULAR, INC.
|
CA
|
$50,000
|
|
Pneumonia
|
2017
|
NIAID
|
1R01AI129996-01A1
|
|
Host Response and Immunity to Yersenia pestis Infection
|
ANDERSON, DEBORAH
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$373,364
|
|
Pneumonia
|
2017
|
NHLBI
|
2R01HL111449-06
|
|
Inducible epithelial resilience during pneumonia
|
QUINTON, LEE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$411,250
|
|
Pneumonia
|
2017
|
NHLBI
|
1R01HL135239-01A1
|
|
Mitochondrial quality control and alveolar damage resolution after acute lung injury
|
PIANTADOSI, CLAUDE
|
DUKE UNIVERSITY
|
NC
|
$397,500
|
|
Pneumonia
|
2017
|
NHLBI
|
1R01HL133336-01A1
|
|
Innate Immunity in Pneumonic Sepsis
|
CAI, SHANSHAN
|
LOUISIANA STATE UNIV A&M COL BATON ROUGE
|
LA
|
$370,000
|
|
Pneumonia
|
2017
|
NHLBI
|
1R01HL138639-01
|
|
HIV-associated gut microbiome affects lung immunity and pneumococcal immune response
|
PALMER, BRENT
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$469,489
|
|
Pneumonia
|
2017
|
NIAID
|
1K99AI128029-01A1
|
|
Characterization of pneumococcal secretion chaperones required for virulence
|
CAHOON, LATY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$125,442
|
|
Pneumonia
|
2017
|
NIAID
|
1K08AI127714-01A1
|
|
VIRULENCE REGULATION AND PROTECTIVE IMMUNITY IN KLEBSIELLA PNEUMONIA
|
ROSEN, DAVID
|
WASHINGTON UNIVERSITY
|
MO
|
$175,738
|
|
Pneumonia
|
2017
|
NIAID
|
1R21AI128569-01A1
|
|
Regenerative therapy for lung infection by S. pneumoniae
|
SHEN, HAO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$255,815
|
|
Pneumonia
|
2017
|
NHLBI
|
3R01HL126711-03S1
|
|
Combined viral and bacterial infection and zinc homeostasis in distal lung
|
KAYNAR, A. MURAT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$16,382
|
|
